Treatment Trials

3 Clinical Trials for Various Conditions

Focus your search

      TERMINATED
      A Two-year Open-label Extension Study of Ganaxolone in Patients With Drug-resistant Partial-onset Seizures
      Description

      A follow-on, two-year open-label extension study of ganaxolone as add-on therapy in adult patients with drug-resistant partial-onset seizures

      Conditions
      Drug Resistant Partial Onset Seizure
      Talk to us
      COMPLETED
      Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension
      Description

      The study will evaluate the effectiveness and safety of an investigational drug-ganaxolone - on partial seizure frequency in adults with epilepsy taking a maximum of 3 antiepileptic medications (AEDs).

      Conditions
      Drug Resistant Partial Onset Seizure
      Talk to us
      TERMINATED
      RNS System RESPONSE Study
      Description

      To demonstrate that the RNS System is safe and effective as an adjunctive therapy in individuals age 12 through 17 years with medically refractory partial onset epilepsy.

      Conditions
      EpilepsyPartial SeizureNeurostimulator; ComplicationsDrug Resistant EpilepsyFocal Epilepsy
      Talk to us